Northcoast Research Research Analysts Lower Earnings Estimates for DENTSPLY SIRONA Inc. (XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Research analysts at Northcoast Research lowered their Q2 2017 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Tuesday. Northcoast Research analyst E. Snyder now expects that the medical instruments supplier will earn $0.64 per share for the quarter, down from their previous forecast of $0.65. Northcoast Research also issued estimates for DENTSPLY SIRONA’s FY2017 earnings at $2.80 EPS, Q2 2018 earnings at $0.75 EPS and FY2018 earnings at $3.23 EPS.

A number of other equities research analysts have also weighed in on the stock. BidaskClub downgraded shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Zacks Investment Research raised shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $72.00 target price on the stock in a research report on Thursday, July 13th. Credit Suisse Group reissued an “outperform” rating and set a $75.00 target price (up previously from $67.00) on shares of DENTSPLY SIRONA in a research report on Thursday, July 13th. HC Wainwright assumed coverage on shares of DENTSPLY SIRONA in a research report on Tuesday, July 11th. They set a “buy” rating and a $74.00 target price on the stock. Finally, Cleveland Research raised shares of DENTSPLY SIRONA from a “neutral” rating to a “buy” rating in a research report on Tuesday, May 23rd. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and nine have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $67.92.

COPYRIGHT VIOLATION NOTICE: “Northcoast Research Research Analysts Lower Earnings Estimates for DENTSPLY SIRONA Inc. (XRAY)” was originally posted by BNB Daily and is the property of of BNB Daily. If you are viewing this piece of content on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.baseball-news-blog.com/2017/08/14/northcoast-research-research-analysts-lower-earnings-estimates-for-dentsply-sirona-inc-xray-updated.html.

Shares of DENTSPLY SIRONA (NASDAQ:XRAY) opened at 61.16 on Wednesday. The firm has a 50-day moving average of $63.88 and a 200-day moving average of $62.25. The stock has a market cap of $14.02 billion, a PE ratio of 39.36 and a beta of 1.26. DENTSPLY SIRONA has a one year low of $55.00 and a one year high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Tuesday, May 9th. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by $0.01. DENTSPLY SIRONA had a net margin of 9.42% and a return on equity of 7.37%. The company had revenue of $900.50 million for the quarter, compared to analysts’ expectations of $916.55 million. During the same quarter in the prior year, the firm earned $0.69 EPS. DENTSPLY SIRONA’s quarterly revenue was up 16.6% compared to the same quarter last year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 13th. Stockholders of record on Friday, September 29th will be given a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, September 28th. DENTSPLY SIRONA’s payout ratio is currently 22.58%.

Hedge funds and other institutional investors have recently modified their holdings of the company. Pinnacle Financial Partners Inc. purchased a new position in shares of DENTSPLY SIRONA during the second quarter worth about $864,000. Advisors Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 18.0% in the second quarter. Advisors Asset Management Inc. now owns 128,952 shares of the medical instruments supplier’s stock worth $8,361,000 after buying an additional 19,679 shares during the last quarter. Teacher Retirement System of Texas increased its position in shares of DENTSPLY SIRONA by 144.6% in the second quarter. Teacher Retirement System of Texas now owns 176,301 shares of the medical instruments supplier’s stock worth $11,431,000 after buying an additional 104,216 shares during the last quarter. DekaBank Deutsche Girozentrale purchased a new position in shares of DENTSPLY SIRONA during the second quarter worth about $6,186,000. Finally, First Trust Advisors LP increased its position in shares of DENTSPLY SIRONA by 8.6% in the second quarter. First Trust Advisors LP now owns 323,240 shares of the medical instruments supplier’s stock worth $20,959,000 after buying an additional 25,544 shares during the last quarter. 94.97% of the stock is currently owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply